- Home
- BRLT vs ANVS Comparison
BRLT vs ANVS Comparison
Compare BRLT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- ANVS
- Stock Information
- Founded
- BRLT 2005
- ANVS 2008
- Country
- BRLT United States
- ANVS United States
- Employees
- BRLT N/A
- ANVS N/A
- Industry
- BRLT Consumer Specialties
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- ANVS Health Care
- Exchange
- BRLT Nasdaq
- ANVS Nasdaq
- Market Cap
- BRLT 21.8M
- ANVS 24.2M
- IPO Year
- BRLT 2021
- ANVS 2020
- Fundamental
- Price
- BRLT $1.41
- ANVS $3.21
- Analyst Decision
- BRLT Hold
- ANVS Strong Buy
- Analyst Count
- BRLT 3
- ANVS 5
- Target Price
- BRLT $1.80
- ANVS $34.75
- AVG Volume (30 Days)
- BRLT 59.8K
- ANVS 593.2K
- Earning Date
- BRLT 05-06-2025
- ANVS 05-13-2025
- Dividend Yield
- BRLT N/A
- ANVS N/A
- EPS Growth
- BRLT N/A
- ANVS N/A
- EPS
- BRLT N/A
- ANVS N/A
- Revenue
- BRLT $418,708,000.00
- ANVS N/A
- Revenue This Year
- BRLT $3.79
- ANVS N/A
- Revenue Next Year
- BRLT $3.85
- ANVS N/A
- P/E Ratio
- BRLT N/A
- ANVS N/A
- Revenue Growth
- BRLT N/A
- ANVS N/A
- 52 Week Low
- BRLT $1.25
- ANVS $1.11
- 52 Week High
- BRLT $2.68
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- BRLT 45.92
- ANVS 75.97
- Support Level
- BRLT $1.39
- ANVS $1.95
- Resistance Level
- BRLT $1.49
- ANVS $3.48
- Average True Range (ATR)
- BRLT 0.06
- ANVS 0.29
- MACD
- BRLT 0.00
- ANVS 0.11
- Stochastic Oscillator
- BRLT 53.57
- ANVS 84.57
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.